ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,481Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 64

$780K Total Retail Price of All Prescriptions

Rank: 3 out of 64

804 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,047 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
CARVEDILOL 1,024 890 1 2
SIMVASTATIN 987 872 2 3
METOPROLOL SUCCINATE 602 570 3 10
CLOPIDOGREL 562 481 4 4
ISOSORBIDE MONONITRATE ER 538 473 5 16
LISINOPRIL 417 361 6 7
PLAVIX 412 358 7 9
AMLODIPINE BESYLATE 335 284 8 5
CRESTOR 330 282 9 12
FUROSEMIDE 313 269 10 6
WARFARIN SODIUM 297 281 11 11
NIASPAN 270 205 12 33
AMIODARONE HCL 269 254 13 28
LOSARTAN POTASSIUM 262 250 14 13
METOPROLOL TARTRATE 249 213 15 1
RAMIPRIL 220 181 16 23
NITROSTAT 195 168 17 21
EFFIENT 185 172 18 20
COREG CR 171 107 19 53
MULTAQ 171 151 19 35
POTASSIUM CHLORIDE 166 153 21 17
RANEXA 159 138 22 24
FENOFIBRATE 159 135 22 44
HYDROCHLOROTHIAZIDE 154 145 24 22
ATORVASTATIN CALCIUM 138 114 25 8
DIGOXIN 129 124 26 18
XARELTO 95 70 27 43
LOSARTAN-HYDROCHLOROTHIAZIDE 91 88 28 41
PROPAFENONE HCL 90 85 29 69
TRILIPIX 88 72 30 64
PRADAXA 84 84 31 26
LOVAZA 83 62 32 67
PANTOPRAZOLE SODIUM 80 65 33 50
CILOSTAZOL 79 68 34 49
VYTORIN 78 78 35 70
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 73 36 61
DILTIAZEM ER 72 45 37 47
DILTIAZEM 24HR CD 59 54 38 37
DIOVAN 55 50 39 34
BENAZEPRIL HCL 54 26 40 25
PRAVASTATIN SODIUM 54 40 40 14
EXFORGE 52 44 42 72
BYSTOLIC 52 52 42 30
OMEPRAZOLE 51 49 44 56
ATENOLOL 50 50 45 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.